Quality Control Processes at Zeptide Pharma
When manufacturing sterile injectable medications, there is zero margin for error. Because these drugs bypass the body’s natural defense mechanisms and enter directly into the bloodstream or tissue, any contamination, incorrect dosage, or formulation error can be life-threatening.
As a trusted CDMO and government partner, Zeptide Pharma implements a rigorous, multi-layered Quality Control (QC) and Quality Assurance (QA) framework. Our protocols span from incoming raw material verification to final batch release, ensuring every vial, syringe, and auto-injector meets stringent global regulatory standards before commercial distribution.
Here is a detailed look at the comprehensive quality control steps and batch release tests we perform to guarantee the safety, purity, and efficacy of our sterile injectables.
In-Process Quality Controls (IPQC)
Quality is built into the product during manufacturing, not just tested at the end. Our continuous in-process monitoring ensures that the batch remains within strict specifications at every stage of production.
- Environmental Monitoring: Viable and non-viable particle counters continuously monitor the Grade A (ISO 5) sterile filling zones. Real-time SCADA systems track temperature, humidity, and differential pressure.
- Pre-Filtration Bioburden Testing: Before the drug solution passes through the sterilizing filters, samples are tested to ensure the microbial load is well within acceptable limits, preventing filter overload.
- Fill Weight and Volume Checks: Automated rotary pumps are integrated with precision load cells that perform statistical check-weighing continuously during the fill-finish process. This guarantees exact dosing and triggers automatic line adjustments if out-of-trend data is detected.
- Headspace Gas Analysis: For oxygen-sensitive formulations like epinephrine, automated laser-based headspace analyzers verify that the nitrogen blanketing process has successfully displaced oxygen inside the sealed container.
Comprehensive Final Batch Release Testing
Once the sterile fill-finish process is complete, a statistically representative sample of the finished product is transferred to our QC laboratories. A batch cannot be released to the market until it passes a comprehensive suite of analytical and microbiological tests.
Microbiological Testing
- Sterility Testing: This is the most critical test for any injectable. Samples are incubated in specialized growth media for 14 days to confirm the absolute absence of aerobic and anaerobic bacteria, as well as fungi. We utilize both direct inoculation and membrane filtration methods in dedicated sterile isolators to prevent false positives.
- Bacterial Endotoxin (Pyrogen) Testing: Even if bacteria are destroyed during sterilization, their residual cell walls (endotoxins) can cause severe fever reactions in patients. We utilize the Limulus Amebocyte Lysate (LAL) assay to ensure endotoxin levels remain far below regulatory safety limits.
Physical and Container Integrity Testing
- 100% Automated Visual Inspection (AVI): Before lab sampling, every single unit passes through AI-powered 360-degree cameras to detect glass defects, cracks, and cosmetic imperfections.
- Particulate Matter Testing: In addition to AVI, QC scientists perform subvisible particulate testing using light obscuration or microscopic analysis to detect microscopic particles that are invisible to the naked eye.
- Container Closure Integrity Testing (CCIT): Ensuring the sterile barrier is maintained throughout the drug's shelf life is vital. We use deterministic, non-destructive technologies like High-Voltage Leak Detection (HVLD) and vacuum decay to detect microscopic breaches in the glass or elastomeric stopper.
- Extractable / Deliverable Volume: Tests are conducted to verify that a medical professional or patient can extract the exact labeled dose from the vial or syringe using standard clinical techniques.
Analytical and Chemical Testing
- Assay and Potency: Using advanced chromatography (HPLC or GC), our analytical chemists measure the exact concentration of the active pharmaceutical ingredient (API) to ensure it perfectly matches the label claim.
- Impurities and Degradation Products: The same chromatographic methods are used to screen for unwanted byproducts or chemical degradation, ensuring the formulation remains pure and stable.
- pH and Osmolality: The solution is tested to ensure its pH and concentration of solutes (osmolality) perfectly match physiological conditions, preventing tissue irritation or pain upon injection.
Final Quality Assurance (QA) Release
Testing the product is only one half of the batch release process; verifying the integrity of the manufacturing data is the other.
Zeptide Pharma utilizes 21 CFR Part 11 compliant Manufacturing Execution Systems (MES). Our QA team conducts a comprehensive review of the Electronic Batch Record (EBR), which compiles:
- Raw material certificates of analysis.
- Operator logs and equipment calibration records.
- Sterilization cycle data (autoclave and dry heat tunnel readouts).
- Environmental monitoring data from the exact time of filling.
- All laboratory test results and out-of-specification investigations (if any).
Only when the QA Authorized Person verifies that every test has passed, all data is pristine, and standard operating procedures (SOPs) were flawlessly followed, is the Certificate of Analysis (CoA) signed. At this point, the batch is officially released for distribution to government stockpiles, hospitals, and pharmacies worldwide.
To establish a Professional Partnership:
Contact MayMag Biologics (Formerly Tirzepatide Pharma / Zeptide Pharma)
Partner with a premier USA-based, FDA-registered 503B/506E CDMO and IND facility. As a leading sterile API manufacturer and large-scale industrial supplier, we provide comprehensive manufacturing solutions for a wide range of critical care and specialized therapeutics, including:
- Diabetic Care & Biosimilars: Insulin 70/30 pens, glargine, and advanced biosimilars.
- Injectables & Auto-Pens: Auto-injector medications and epinephrine delivery systems.
- Specialized Treatments: Weight-loss therapies, nasal sprays, and ophthalmic products.
- Essential Preparations: Sterile and bacteriostatic waters.
